Leadership Team

Mr. Kansler serves as the Chief Executive Officer of Inovalon where he is responsible for the overall execution of the Company's strategy, vision, growth, and performance as it executes on its mission to be the industry's leading provider of software and data solutions empowering superior outcomes and economics in healthcare.

Prior to joining Inovalon, Mr. Kansler served as President of S&P Global Market Intelligence, the $4.5 billion annual revenue and 18,000 team member division of S&P Global (NYSE: SPGI), the world's largest diversified data solutions provider. Focused on delivering leading data, analytics and software solutions at S&P Global, Mr. Kansler drove new software and data products, the introduction of more than a dozen GenAI-driven solutions, multiple successful acquisitions, extensive cloud compute and operational efficiency initiatives, and the establishment of S&P Global's cross-firm executive function for Enterprise Data.

Prior to his role as divisional President at S&P Global, Mr. Kansler served as President of the Financial Services division and member of the executive team for IHS Markit where he was responsible for the business' data, analytics, platforms and software solutions as the company grew from a valuation of approximately $13 billion in 2016 to its acquisition by S&P Global for $44 billion in 2022. Preceding his tenure as divisional President at IHS Markit, Mr. Kansler served as the company's Chief Administrative Officer and General Counsel where he led the human resources, legal, corporate communications, risk, regulatory affairs and strategic alliances functions.

Before joining IHS Markit, Mr. Kansler spent 17 years with the law firm of Proskauer LLP as a corporate partner where he focused on capital markets and financing transactions, M&A, complex strategic partnerships and joint-ventures, and regulatory policy and compliance initiatives.

Mr. Kansler holds a B.A. in economics from Hobart College and received his J.D. from Columbia University School of Law.

John Barneson serves as the President and Chief Operating Officer of Inovalon, where he is responsible for the company’s overall operational performance, strategic execution, and delivery of market-leading software and data solutions. In this role, Mr. Barneson oversees Inovalon’s four business units – Payer, Provider, Pharmacy, and Insights – as well as the company’s product and technology organizations.

Prior to joining Inovalon, Mr. Barneson led the Enterprise Solutions segment at S&P Global, a 6,000 team member business generating over $1.2 billion in annual revenue. Under his leadership, Enterprise Solutions achieved an average annual revenue growth rate of 16%. The segment’s offerings spanned software, services, and data solutions for lending, private and capital markets, corporate actions, regulatory reporting, tax, risk and compliance, and enterprise data management. He also served on the board of OSTTRA, a post-trade joint venture with the CME Group which has been acquired by KKR in 2025.

Earlier in his career, Mr. Barneson held leadership roles in both the United States and Europe. At Rauxa (now part of Publicis), he directed global strategy, technology, data science, analytics, media, finance, and operations. As a Managing Director at Bay Capital, he led M&A advisory services for clients in wireless, energy, cloud computing, e-commerce, software, and marketing. He has also held leadership positions in cloud computing and marketing, and served as a marketing and communications board member for the Entrepreneur’s Foundation.

Mr. Barneson is an active supporter of the Children’s Diabetes Foundation and the Barbara Davis Center. He holds a Bachelor of Arts degree in Economics from Stanford University.

Ed Chidsey serves as the President of Inovalon's Life Sciences & Payer Businesses, leading the Company's provision of data solutions to organizations throughout the healthcare ecosystem, empowering the application of unique data to deliver better outcomes and economics. In this role, Mr. Chidsey leads and is responsible for the management, product portfolio, sales, customer success, operations, and overall performance of the Real-World Data & Insights and Payer businesses.

Prior to his role at Inovalon, Mr. Chidsey was Senior Vice President and global head of the Data, Valuations & Analytics business within S&P Global's Market Intelligence division. In that capacity, he had full responsibility for a $1 billion revenue portfolio covering cross-asset class Market Data, Reference Data, Valuation, and Company Information Services across public, OTC, and private markets.

Mr. Chidsey joined S&P Global after its merger with IHS Markit in 2022, where he had been since 2007 and was a Partner with responsibility for the Information Services business. He was a member of the senior management team that drove rapid growth of Markit as a private company, leading to a Nasdaq listing in 2014 and the merger with IHS in 2016.

Mr. Chidsey holds a Master of Business Administration from Columbia University and holds a Bachelor of Science in Mechanical Engineering from Union College.

Karly Rowe serves as the President of Inovalon’s Provider Solutions. In this role, Ms. Rowe leads the organization that delivers software solutions to tens of thousands of provider organizations across the country, empowering them to achieve better outcomes and economics for their organizations and the millions of patients that they serve. Ms. Rowe leads and is responsible for the management, product portfolio, sales, customer success, operations, and overall performance of the Provider business.

Prior to her role as President, Ms. Rowe was the Senior Vice President of Product Management for Inovalon's Provider Solutions spanning revenue cycle management, workforce management, and care management.

Ms. Rowe held several leadership roles at Experian across both the credit and healthcare verticals of the business prior to joining Inovalon. She was responsible for product and strategy, bringing numerous products to market and establishing and maintaining strategic partnerships with electronic health records (EHRs), technology vendors, and pharmacy standard organizations.

Ms. Rowe holds a Master of Business Administration from Arizona State University and a Bachelor of Arts in Marketing Management and Retail Management from Syracuse University.

Ernie Shopes serves as the President of Inovalon’s Pharmacy Solutions, where he leads the organization’s focus on bring the capabilities of Inovalon’s data and solutions to pharmacy customers with the goal of empowering superior outcomes and economics. In this role, Mr. Shopes leads and is responsible for the management, product portfolio, sales, customer success, operations, and the overall performance of Inovalon’s Pharmacy business.

A respected veteran and acknowledged thought-leader across the industry, Mr. Shopes has spent more than 30 years leading a broad array of teams innovating, developing, and supporting software solutions that improve patient outcomes, decrease time to therapy, and reduce the total costs of operations and care for many of the nation’s largest pharmacies. During his tenure within the industry, Mr. Shopes has led the personnel teams responsible for product, customer success, implementation, operations, and engineering. Key to the early innovations of modern pharmacy operations software, Mr. Shopes tenure has been instrumental to the growth of ScriptMed, the industry’s most widely utilized pharmacy operations software solution, now supporting more than 35% of the market’s Specialty Pharmacy segment, and key to Inovalon leadership in specialty pharmacy and infusion solutions.

Prior to time spent in the healthcare industry, Mr. Shopes spent several years with the Department of Defense in Texas and New Jersey and played a key role as a civilian in Operation Desert Storm for the Department of the Army serving as liaison between the Emergency Operations Center (EOC) and the teams supplying electronic equipment to troops in Southwest Asia.

Mr. Shopes earned his Graduate Degree, with a focus on international business, and bachelor’s degree in business, both from Duquesne University.

Ms. Allen serves as the Chief Legal Officer, Chief Compliance and Privacy Officer and Corporate Secretary for Inovalon, overseeing and leading all legal matters, the corporate compliance program and privacy program for Inovalon and its affiliates. This includes providing strategic and business advice on a wide range of legal topics including commercial matters, data privacy, regulatory compliance, litigation, employment, corporate governance, risk management and health care law, as well as various other strategic and corporate transactions.

Prior to joining Inovalon in 2016, Ms. Allen was the Chief Integrity Officer at MedStar Washington Hospital Center in Washington, D.C., a nationally recognized healthcare provider. In that capacity, she led the compliance, privacy, investigations and regulatory audit functions. Ms. Allen’s previous experience also includes various leadership roles with Booz Allen Hamilton and SRA International where she was responsible for developing, leading and overseeing legal, compliance, risk management, privacy and information security solutions across the federal and commercial sectors and assessing the privacy and security impact and risks associated with new and emerging products and technologies. In addition, Ms. Allen served as a Senior Attorney Advisor for the U.S. Department of Education, District of Columbia Enforcement Office, where she led numerous legal and compliance initiatives and a variety of complex and high-profile investigations. Ms. Allen also was a Senior Advisor for the Department of Homeland Security where she conceptualized and directed initiatives designed to implement various compliance mandates across the department and its component organizations.

Ms. Allen is a member of the Board of Directors of Intapp, a leading global provider of cloud solutions for professionals at advisory, capital markets and legal firms. Ms. Allen also serves on the Board of the Appleseed Network, a nonprofit network of justice centers across the United States and Mexico. Additionally, Ms. Allen is a member of the Legal Ethics Committee of the District of Columbia Bar.

Ms. Allen received her Bachelor of Arts from the University of Virginia, Juris Doctor from the University of North Carolina and a Master’s degree from Georgetown University.

Kris Allen serves as Chief Financial Officer of Inovalon, where he leads the Company's finance organization and partners with the executive team to drive growth, strengthen financial performance, and build the disciplined financial foundation to support Inovalon's continued scale.

Mr. Allen has more than 20 years of finance and leadership experience across public companies and private equity-backed businesses, most recently as Chief Financial Officer of North America at NielsenIQ (NIQ), where he partnered with business leaders to drive growth and improve performance, and helped guide the company through its transition to the public markets. He was also part of the core finance leadership team responsible for planning and executing NIQ's IPO and establishing its public-company finance and reporting capabilities. Over his career, Mr. Allen has held finance leadership roles spanning FP&A, investor relations, accounting, and strategic finance, and has played key roles in large capital markets transactions, including two IPOs, debt financing, and numerous M&A transactions.

Earlier in his career, Mr. Allen held senior leadership roles in FP&A and controllership at TransUnion and began his career at KPMG, where he was a registered CPA.

Mr. Allen holds a master's degree from the University of Notre Dame and a bachelor's degree in finance from Texas Christian University.

Dr. Kilian serves as the Chief Medical Officer (CMO) for Inovalon. In this role, Dr. Kilian is responsible for the oversight of the medical directors of the Company, the clinical content and design of the Company’s software and analytics, and the clinical training, quality, policies, oversight, and compliance of associated operations. For more than a decade, Dr. Kilian has led a team of clinical personnel who bring the latest best practices and evidence-based clinical standards to Inovalon’s products and services. Dr. Kilian is well known throughout the healthcare community as an expert on the application of data, software, and analytics to the benefit of clinical protocols, care guidelines, real-world healthcare clinical workflow, and regulatory policy guidelines adherence. Most recently, Dr. Kilian has been recognized with the Healthcare Business Women’s Association 2020 Luminary award.

Prior to joining Inovalon in 2007, Dr. Kilian was in clinical practice with Johns Hopkins Community Physicians, where she served as Medical Director with responsibilities including patient care, clinical training of medical students and residents, and clinical oversight of a multispecialty practice.

Dr. Kilian graduated summa cum laude from Washington and Lee University and earned her doctorate in medicine from Tufts University School of Medicine. She completed her residency in Internal Medicine at The Johns Hopkins Hospital in Baltimore, Maryland.

Bill Huan serves as the Chief Information Security Officer for Inovalon. In this role, Mr. Huan leads and is responsible for the oversight, management and execution of the Company’s cybersecurity, information security, and application security functions as well as security architecture, engineering, and operations aspects for all security domains.

Prior to Inovalon, Mr. Huan was the Chief Information Security Officer at mParticle, a MarTech SaaS company, where he led and managed all facets of security, including but not limited to, security engineering, cloud security, application security, compliance, incident response, penetration testing, vulnerability management, risk management, and vendor management. In this role, Mr. Huan led the development of next-generation cloud security technologies, including zero-trust architecture, insider threat mitigations, data leakage protections, secure CI/CD pipelines, and micros-services security; was responsible for securing billions of sensitive PII records for large enterprise customers, such as major banks, retailers, and media companies; and supported the achievement of HIPAA, SOC, ISO 27001, and GDPR compliance across the platform. Before mParticle, Mr. Huan was the Chief Security Officer at Zuora, a publicly traded Fintech company, where he was responsible for securing $50B+ in annual payment transactions, led security governance and risk management, and achieved PCI, ISO 2700X, and SOC2 certifications. Mr. Huan also held leadership positions at McAfee and Intel, where he led the development of various cybersecurity technologies that protected many of the Fortune 500 companies and supported billions in total sales.

Mr. Huan holds both a Bachelor of Science degree and a Master of Science degree from Stanford University.

Eric Maldonado serves as Chief Sales Officer at Inovalon, where he leads the company’s global revenue organization and is responsible for driving commercial strategy, go-to-market execution, and revenue growth across Inovalon’s portfolio of solutions.

Prior to joining Inovalon, Mr. Maldonado served as Chief Commercial Officer and Senior Vice President, Global Head of Sales & Marketing for S&P Global Market Intelligence, where he oversaw the division’s global commercial operations, including revenue acquisition, retention, and customer engagement.

Mr. Maldonado joined S&P Global through its 2022 merger with IHS Markit. Prior to the merger, he held multiple leadership roles at IHS Markit after joining the company in 2006 through its acquisition of Communicator, where he had been a partner and global head of sales. During his tenure, he led global sales organizations and supported the company’s growth across multiple industry segments.

Earlier in his career, Mr. Maldonado held sales leadership roles across emerging technology companies, several of which later achieved successful IPOs or strategic acquisitions. He began his career in sales roles with 3M and ADP.

Mr. Maldonado holds a Bachelor of Business Administration from Florida International University’s College of Business Administration.

Melanie Margolin serves as the Chief Administrative Officer of Inovalon. In this role, Ms. Margolin brings together several core enterprise functions, including People, Procurement, Real Estate & Workplace Services, Internal Communications, Public Relations & Analyst Relations, Corporate Technology, Infrastructure, & Security, and Corporate Safety & Security, in order to drive combined operational rigor and enterprise focused results.

With more than 25 years of executive legal and business leadership experience at public and private companies, Ms. Margolin has a proven record of building high-performing, cross-functional teams that partner with the business to deliver results. She is recognized for her practical, business-first approach to strategic guidance at the company, board, and investor levels.

Prior to Inovalon, Ms. Margolin served as Chief Administrative and Legal Officer at Clarivate, where her multi-functional team spanned legal, human resources, communications and brand, real estate and facilities, and governance functions. She previously served as Chief Legal Officer at Thumbtack; General Counsel and Corporate Secretary at Wabash National Corporation; and Deputy General Counsel at Cummins Inc.

Ms. Margolin holds a Juris Doctor from DePaul University College of Law and a Bachelor of Science in Communications from the University of Illinois at Urbana-Champaign, and she is a graduate of the Executive Finance program at Harvard Business School.

Vikas Sahni serves as Chief Product Officer of Inovalon, where he leads product development and engineering across the Company's four business units – Payer, Provider, Pharmacy, and Real-World Data & Insights – responsible for product strategy, roadmap, and innovation to deliver customer-centric, market-leading solutions.

Prior to joining Inovalon, Mr. Sahni spent more than 15 years at S&P Global and its predecessor IHS Markit in senior product and strategy leadership roles, most recently as SVP and Managing Director, Head of Software for Enterprise Solutions, where he led a $350 million portfolio of data management and trading workflow solutions and directed a global team of more than 1,800 professionals serving 900-plus clients, driving double digit annual growth. He previously served as Managing Director, Head of Product for Network & Regulatory Solutions, where he managed a $500 million-plus product portfolio, and built and led a 400-person cross-functional team spanning technology, revenue, client success, and operations.

Earlier in his career, Mr. Sahni led product and presales for IHS Markit's corporate actions and securities processing solutions and began his career as an Associate Consultant at Tata Consultancy Services.

Mr. Sahni holds a Bachelor of Engineering in Electrical Engineering from Punjab Engineering College, Chandigarh.

Xiaodan Zhang serves as Head of Business Performance for Inovalon, where she leads the function responsible for enterprise-wide performance management, business analytics, transformation and integration, and the Company's internal AI innovation efforts.

Prior to joining Inovalon, Ms. Zhang spent more than a decade at S&P Global and IHS Markit in a series of senior operating and strategy roles, most recently as Head of Business Performance Strategy for Enterprise Solutions, a multi-billion-dollar portfolio of software, services, and data solutions. In that role, she built the enterprise-wide KPI framework and analytics platform that embedded data-driven decision-making at the executive level, and led global teams that strengthened governance, resource allocation, and performance measurement across the business. She previously served as Vice President, COO for IHS Markit's Financial Software Solutions, and held leadership roles across enterprise data management, investment management, and private markets software, including EDM, thinkFolio, and Global Product Services.

Earlier in her career, Ms. Zhang held roles in strategy, professional services, and trading at Markit and TD Securities, where she founded and built a new group to evaluate issuer data and strengthen trading limit controls and governance.

Ms. Zhang holds a Master of Business Administration from the University of Cambridge, UK, and a Bachelor of Commerce from Queen's University, Canada.

Mr. Creehan serves as a Fellow of Pharmacy Solutions at Inovalon, a role created to recognize Mr. Creehan for a distinguished career at Inovalon and Creehan. In this role, Mr. Creehan supports key pharmacy software platform relationships, industry thought-leadership, and product strategy, design, and development initiatives at Inovalon.

Mr. Creehan previously served as president and general manager of Inovalon’s pharmacy software business where he led the Company’s design, development, advancement, and support of data-driven pharmacy solutions.

Mr. Creehan has a 25 year history of pharmacy technology solution development and implementation and is the founder of Creehan and company, the industry’s leading provider of enterprise software for the pharmacy marketplace. After combining Creehan and company with Inovalon in 2016, Mr. Creehan has led the strategy and innovation of the Company’s next generation pharmacy platform solution. Leveraging a modular cloud-based architecture, and the data, connectivity, and analytical capabilities of the Inovalon ONE® Platform, ScriptMed Specialty is the industry’s most advanced enterprise pharmacy platform.

Mr. Creehan has a proven track record for driving business growth from start-up pharmacies to several Fortune 500 clients through technology and innovation, and is an established industry thought leader. He has played an active role in advancing technology and automation for clinical decision support, care coordination, pharmacy practice, and pharmaceutical distribution. Providing the strategy, vision, and architecture for the company’s technologies, Mr. Creehan has lead the company to the number one market position in specialty pharmacy, and establishment of leading technology for driving clinical quality and patient outcomes in pharmacy.

Mr. Creehan holds a B.S. in Information Systems from Robert Morris University and is a graduate of the Entrepreneurial Management Program at Carnegie Mellon University. He is active in the pharmacy community and is a member of several industry associations.

Dr. David Goldsteen serves as a Fellow of Provider Safety and Surveillance for the Provider business at Inovalon, a role created to recognize Dr. Goldsteen for his distinguished career, culminating in his tenure as Founder, Chairman and CEO of VigiLanz. In this role as Fellow, Dr. Goldsteen supports key provider software relationships and product strategy, leveraging his 20+ years of industry expertise and experience advancing the delivery of data-driven patient care.

Dr. Goldsteen is the co-founder of VigiLanz and most recently served as Chairman and CEO. In this role, his leadership and line of sight into future needs of healthcare providers enabled him to oversee the development and enhancement of groundbreaking technologies that support clinical surveillance as well as patient safety and quality outcomes. Dr. Goldsteen is also a founder and former Chairman and CEO of Vascular Science, Inc., purchased by St. Jude Medical (NASDAQ:STJ). Dr. Goldsteen’s strategic insights are further reflected in his work founding and remaining a Managing Partner of Global Capital Investments, LLC, a boutique merchant banking group.

Dr. Goldsteen's portfolio of achievements also includes roles as a board member and financier for innovative enterprises such as SurVivaLink, a medical device manufacturer sold to Cardiac Science (NASDAQ:DFIB), MediaDVX, a digital media provider sold to NetStar LP, InfoPet, a veterinary microchipping company, and Quantech, Ltd, a medical diagnostics company. His early career was marked by significant contributions to the medical field; from 1988–1993 he served as Vice President of Medical Affairs for Emergency Services at Health One, a predecessor of Allina Hospitals and Clinics, a diversified healthcare delivery organization.

Dr. Goldsteen is a graduate of the University of Minnesota Medical School. He honed his medical expertise through his residency in Internal Medicine at Hennepin County Medical Center in Minneapolis, MN. He received board certifications in internal medicine and emergency medicine. Dr. Goldsteen received his M.B.A. in 1994 from the Carlson School of Management at the University of Minnesota

Mr. Rizzo serves as a Fellow of Innovation for Inovalon, a role created to recognize Mr. Rizzo for a distinguished career at Inovalon. In this role, Mr. Rizzo mentors emerging leaders within the Company and supports product strategy, innovation, and go-to-market initiatives of the Company.

Prior to this role, Mr. Rizzo served in many key roles at Inovalon since his joining the Company in 2002, and most recently as Chief Innovation Officer for Inovalon until 2016. In this role, Mr. Rizzo was responsible for the coordination and oversight of all product development and material product updates and expansions of capability; including design, functionality, development, quality testing processes, and modularized rollouts and operational expansions. Mr. Rizzo was also responsible for all aspects of the Company’s dataset assets, including processes to support and achieve the high integrity, reliability, and security; accuracy and efficiency of integration; comprehensive policies and procedures for the access and utilization; and ultimate realization of value for the Company, clients, and the healthcare community. In addition to these roles, Mr. Rizzo served as the Company’s Security Officer and served in a number of key roles at Inovalon, including the Company’s Chief Product Officer, and was responsible for all major product roll outs since the Company first started major operations.

Prior to joining Inovalon, Mr. Rizzo served as Vice President of Product Development for Founding Advisors, Inc., a specialized management consulting firm. In the service of Founding Advisors, Mr. Rizzo served in various product development roles on behalf of Founding Medical Informatics, Inc. and the Medical Reliance Group, LLC, including leading the technology and software design and development of the core products of Medical Site Reviewers.

Prior to joining Founding Advisors, Mr. Rizzo was a senior consultant at Arthur Andersen, LLP, where he advised clients in the healthcare, telecommunications, and insurance industries. In his capacity as lead analyst, Mr. Rizzo performed in-depth data analysis and financial investigations of health and life insurance companies in order to evaluate appropriate recapture of reinsurance receivables and government coverage for customers of life insurance companies in liquidation. While at the firm, he also performed in-depth industry financial investigations in support of clients’ strategic expansion and investment decisions.

In addition to his Fellow role at Inovalon, Mr. Rizzo serves as a trustee at Loyola University Maryland, where he graduated Summa Cum Laude with a Bachelor of Arts degree in Business Administration, and is highly active in a number of philanthropic organizations serving disadvantages communities in Maryland. Additionally, Mr. Rizzo holds the Chartered Financial Analyst designation and is active within the entrepreneurial, venture capital, and private equity community throughout the mid-Atlantic region.

Mr. Wychulis serves as a Fellow for the Payer business at Inovalon, a role created to leverage Mr. Wychulis’ deep industry experience, expertise, and distinguished career within the marketplace and at Inovalon. In this role, Mr. Wychulis focuses on industry trends and specific strategic client opportunities, relationships, operations, and support for Inovalon’s Payer business.

Prior to this role, Mr. Wychulis was the president and member of the Executive Leadership Team of Inovalon, where he was responsible for the oversight of the Company’s day-to-day operations across its business units and the related industry insight support, client engagement, and strategic relationships. Prior to joining Inovalon in 2014, Mr. Wychulis served as the President of the WellPoint New York government program health plan, HealthPlus, an Amerigroup company, where he was responsible for the full P&L management of the company’s $1.9 billion product portfolio within the New York region. Mr. Wychulis was responsible for oversight of medical management, quality improvement, finance, compliance, human resources, government relations, provider contracting, marketing, enrollment, strategic planning, and the managed long-term care product. Mr. Wychulis played a pivotal role in working with state regulators in transforming New York’s Medicaid delivery system through the state’s Medicaid Redesign Team (MRT), worked on complex premium rate setting issues within the state, and served on the state’s quality incentive committee for the long-term care populations. Under Mr. Wychulis’ direction, the plan realized a 300-percent growth in membership and a 600-percent increase in premium revenue. In 2013, he was awarded WellPoint’s Pinnacle Award, the company’s highest management award. In the same year, HealthPlus was the most profitable of the 20 WellPoint government program plans, while maintaining an upper tier quality and outcome ranking, and achieving NCQA accreditation status for the plan.

Prior to joining WellPoint/Amerigroup, Mr. Wychulis served as President and CEO of the Florida Association of Health Plans, where he expanded the Association from 8 to 26 plans in 4 years. Mr. Wychulis was responsible for driving the successful development of public policy and legislation that resulted in a significant expansion of covered lives and an increase in hundreds of millions of dollars in additional revenue to the Florida managed care plans. He facilitated critical strategic relationships with the hospital, medical, and health advocacy community and associations. Mr. Wychulis also served as President and CEO of HealthPlan Southeast, a North Florida managed care company comprised of state employee, commercial, and Medicaid/CHP contracts. Mr. Wychulis was instrumental in improving the plan’s performance and positioning it to serve as the base for the successful acquisition and integration of multiple Florida managed care organizations that are now Coventry/Aetna Florida.

Mr. Wychulis received his Bachelor of Political Science degree from the City College of New York and his Master of Health Administration and Planning from the Wagner School of Public Administration at New York University.